Osseodensification Versus Osteotome Internal Sinus Lifting in Delayed Implant Placement

Launched by AIN SHAMS UNIVERSITY · Aug 8, 2022

Keywords

ClinConnect Summary

This clinical trial is comparing two different techniques for a procedure called sinus lift, which is used to prepare the upper jaw for dental implants. The two methods being studied are Osseodensification, which is a gentler and less invasive way to lift the maxillary sinus floor, and Osteotome internal sinus lifting, which is a technique that uses special tools to raise the sinus membrane. The goal is to see which method offers better results in terms of bone growth, stability of the implants, and overall satisfaction from patients.

To participate in this trial, individuals should be between 18 and 40 years old and have missing teeth in the upper back jaw area for more than four months. They should also have a certain amount of bone height in that area (between 4 to 6 mm) and be in good health. However, individuals who smoke, are pregnant, have certain medical conditions, or have had previous surgeries on their sinuses may not be eligible. Participants can expect to undergo one of the two techniques and will be monitored for their recovery and satisfaction with the treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patient partially edentulous with maxillary posterior edentulous ridge after extraction of more than 4 months.
• • 2. Both sexes will be selected males and females.
• • 3. Adult patients aged between 18 and 40 years of age.
• • 4. Good general health (American Society of Anesthesiology Physical Status Ⅰ-Ⅱ).
• • 5. Initial residual alveolar ridge height ranging between 4 to 6 mm according to preoperative CBCT.
• • 6. No previous surgery or radiation treatment on the maxillary sinus.
• Exclusion Criteria:
• • 1. Smokers.
• • 2. Pregnant or lactating females.
• • 3. Psychiatric disorders.
• • 4. Uncontrolled systemic disease.
• • 5. Hematologic diseases and coagulation disorders.
• • 6. Chemotherapy or radiotherapy of the head and neck area, and immunocompromised status.
• • 7. Medical conditions affecting bone metabolism and ongoing treatment with bisphosphonates drugs or systemic steroids.
• • 8. Presence of acute or chronic sinus pathoses or sinus membrane perforation.